N/A (Healthy adults)
Conditions
Interventions
None listed
Sponsors
Meiji Co., Ltd.
Tokushima University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects examined in the other study (UMIN000045839)
Exclusion criteria
Exclusion criteria: Subjects whose specimen have not been obtained or remained enough volume for analysis in the other study (UMIN000045839)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Titers and antigen binding-avidity of anti-SARS-CoV-2 antibodies in plasma | — |
Countries
Japan
Contacts
Public ContactToshihiro Sashihara
Meiji Co., Ltd. R&D Division
Outcome results
None listed